PDGF receptor- β modulates metanephric mesenchyme chemotaxis induced by PDGF AA

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 2, 2009, Pages

  Ricono, Jill M ^a,f   Wagner, Brent ^b,c   Gorin, Yves ^b   Arar, Mazen ^d   Kazlauskas, Andrius ^e   Choudhury, Goutam Ghosh ^c   Abboud, Hanna E ^b,c  

^a Institute of Biotechnology   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f University of Texas Health Science Center   (United States)

Author keywords

Calcium; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; GENETIC TRANSFECTION; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 60549116883     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90368.2008     Document Type: Article

References (64)

1. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 57: 297-309, 1995.
2. Adachi T, Togashi H, Suzuki A, Kasai S, Ito J, Sugahara K, Kawata S. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41: 1272-1281, 2005.
3. Arar M, Xu YC, Elshihabi I, Barnes JL, Choudhury GG, Abboud HE. Platelet-derived growth factor receptor beta regulates migration and DNA synthesis in metanephric mesenchymal cells. J Biol Chem 275: 9527-9533, 2000.
4. 2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275: 10527-10531, 2000.
5. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 3: 512-516, 2001.
6. Betsholtz C, Lindblom P, Bjarnegard M, Enge M, Gerhardt H, Lindahl P. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr Opin Nephrol Hypertens 13: 45-52, 2004.
7. Boureux A, Furstoss O, Simon V, Roche S. Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors. J Cell Sci 118: 3717-3726, 2005.
8. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. Oncogenes and signal transduction. Cell 64: 281-302, 1991.
9. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435: 347-353, 2005.
10. Choudhury GG, Grandaliano G, Jin DC, Katz MS, Abboud HE. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Kidney Int 57: 908-917, 2000.
11. Claesson-Welsh L, Eriksson A, Westermark B, Heldin CH. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA 86: 4917-4921, 1989.
12. Diliberto PA, Gordon G, Herman B. Regional and mechanistic differences in platelet-derived growth factor-isoform-induced alterations in cytosolic free calcium in porcine vascular smooth muscle cells. J Biol Chem 266: 12612-12617, 1991.
13. Diliberto PA, Gordon GW, Yu CL, Earp HS, Herman B. Platelet-derived growth factor (PDGF) alpha receptor activation modulates the calcium mobilizing activity of the PDGF beta receptor in Balb/c3T3 fibroblasts. J Biol Chem 267: 11888-11897, 1992.
14. 2+-flux pathways in canine venous endothelial cells. Biochem J 297: 209-215, 1994.
15. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10: 262-267, 1998.
16. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 32: 30-38, 1996.
17. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
18. Eriksson A, Siegbahn A, Westermark B, Heldin CH, Claesson-Welsh L. PDGF alpha- and beta-receptors activate unique and common signal transduction pathways. EMBO J 11: 543-550, 1992.
19. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248-253, 1998.
20. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M, Marx M. Oxidative stress induces tyrosine phosphorylation of PDGF alpha-and beta-receptors and pp60c-src in mesangial cells. Kidney Int 50: 164 -173, 1996.
21. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, Abboud HE. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 15: 1909-1920, 2001.
22. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
23. Grandaliano G, Choudhury GG, Biswas P, Abboud HE. Mitogenic signaling of thrombin in mesangial cells: role of tyrosine phosphorylation. Am J Physiol Renal Fluid Electrolyte Physiol 267: F528-F536, 1994.
24. Grandaliano G, Valente AJ, Rozek MM, Abboud HE. Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells. J Lab Clin Med 123: 282-289, 1994.
25. + channel activation, cell volume changes and eicosanoid formation. Eur J Biochem 211: 449 -458, 1993.
26. Heldin CH, Ernlund A, Rorsman C, Ronnstrand L. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J Biol Chem 264: 8905-8912, 1989.
27. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: 79-113, 1998.
28. 1-integrin-mediated A2058 tumor cell migration to type IV collagen. Am J Physiol Cell Physiol 281: C106-C113, 2001.
29. Horgan AM, Copenhaver PF. G protein-mediated inhibition of neuronal migration requires calcium influx. J Neurosci 18: 4189-4200, 1998.
30. -secreted by monocytes and macrophages. Methods Enzymol 105: 365-369, 1984.
31. 2+ in TGF-beta 1-induced IL-6 expression. J Immunol 165: 2190-2197, 2000.
32. 2+ channel. Mol Pharmacol 53: 497-503, 1998.
33. Klinghoffer RA, Mueting-Nelsen PF, Faerman A, Shani M, Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell 7: 343-354, 2001.
34. Koyama N, Kinsella MG, Wight TN, Hedin U, Clowes AW. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Circ Res 83: 305-313, 1998.
35. Kumasaka S, Shoji H, Okabe E. Novel mechanisms involved in super-oxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum linked to cyclic ADP-ribose stimulation. Antioxid Redox Signal 1: 55-69, 1999.
36. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, Rhee SG. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101: 16419 -16424, 2004.
37. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121: 163-170, 1993.
38. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875-1887, 1994.
39. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2: 302-309, 2000.
40. Lindahl P, Hellstrom M, Kalen M, Karlsson L, Pekny M, Pekna M, Soriano P, Betsholtz C. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125: 3313-3322, 1998.
41. Margolis B, Skolnik EY. Activation of Ras by receptor tyrosine kinases. J Am Soc Nephrol 5: 1288-1299, 1994.
42. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
43. Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, Aaronson S. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243: 800 -804, 1989.
44. Nakashio A, Fujita N, Tsuruo T. Topotecan inhibits VEGF- and bFGF- induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway. Int J Cancer 98: 36-41, 2002.
45. Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin CH. A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52: 791-799, 1988.
46. Okabe E, Kato Y, Sasaki H, Saito G, Hess ML, Ito H. Calmodulin participation in oxygen radical-induced cardiac sarcoplasmic reticulum calcium uptake reduction. Arch Biochem Biophys 255: 464-468, 1987.
47. Okabe E, Kuse K, Sekishita T, Suyama N, Tanaka K, Ito H. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum. J Pharmacol Exp Ther 256: 868 -875, 1991.
48. Okabe E, Sugihara M, Tanaka K, Sasaki H, Ito H. Calmodulin and free oxygen radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum. J Pharmacol Exp Ther 250: 286-292, 1989.
49. Ricono JM, Arar M, Choudhury GG, Abboud HE. Effect of platelet-derived growth factor isoforms in rat metanephric mesenchymal cells. Am J Physiol Renal Physiol 282: F211-F219, 2002.
50. Ricono JM, Xu YC, Arar M, Jin DC, Barnes JL, Abboud HE. Morphological insights into the origin of glomerular endothelial and mesangial cells and their precursors. J Histochem Cytochem 51: 141-150, 2003.
51. Seifert RA, Alpers CE, Bowen-Pope DF. Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int 54: 731-746, 1998.
52. Seifert RA, van Koppen A, Bowen-Pope DF. PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction. J Biol Chem 268: 4473-4480, 1993.
53. 2+ regulation in neuronal and glial cell signalling. Brain Res Brain Res Rev 26: 72-81, 1998.
54. Soriano P. Abnormal kidney development and hematological disorders in PDGF b-receptor mutant mice. Genes Dev 8: 1888-1896, 1994.
55. Soriano P. The PDGF a receptor is required for neural crest cell development and for normal patterning of the somites. Development 124: 2691-2700, 1997.
56. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
57. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
58. 2+ influx in neutrophil-like HL-60 cells. Cell Calcium 29: 409 - 415, 2001.
59. Valius M, Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73: 321-334, 1993.
60. Wagner B, Ricono JM, Gorin Y, Block K, Arar M, Riley D, Choudhury GG, Abboud HE. Mitogenic signaling via platelet-derived growth factor beta in metanephric mesenchymal cells. J Am Soc Nephrol 18: 2903-2911, 2007.
61. Wang XT, McCullough KD, Wang XJ, Carpenter G, Holbrook NJ. Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem 276: 28364-28371, 2001.
62. Wennstrom S, Siegbahn A, Yokote K, Arvidsson AK, Heldin CH, Mori S, Claesson-Welsh L. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphati-dylinositol 3′ kinase. Oncogene 9: 651-660, 1994.
63. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226-232, 1986.
64. Yokote K, Mori S, Siegbahn A, Ronnstrand L, Wernstedt C, Heldin CH, Claesson-Welsh L. Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis. J Biol Chem 271: 5101-5111, 1996.